10-K · June 29, 2026
PetVivo Holdings reported revenues of $1,141,607 for fiscal year ending March 31, 2026, virtually unchanged from $1,132,533 in the prior year. However, the company continues to incur substantial losses, recording a net…
Earnings analysis · 10-Q
PETV earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
The provided 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative outlook, so revenue, margins, EPS, liquidity, and free-cash-flow trends cannot be…
Read full summary
The provided 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative outlook, so revenue, margins, EPS, liquidity, and free-cash-flow trends cannot be assessed. The filing does disclose $750,000 of private-placement proceeds but also substantial equity issuance, including 937,500 placement shares, 368,152 employee-award shares, and 200,000 service-provider shares. The VetStem licensing agreement terminated on July 24, 2026, while OSHA-related risks remain identified as potentially material.
What stood out
-
$750,000 raised in private placement
The company issued 937,500 common shares for $750,000 in private-placement proceeds during April and June 2026, providing additional financing liquidity.
-
Preferred dividends converted to equity
The company issued 176,174 common shares valued at $125,000 to convert dividends declared on Series B preferred stock, eliminating the stated dividend obligation through equity issuance.
-
Equity compensation supported services
The company issued 62,500 shares valued at $42,000 to 5 board members for advisory and consulting services, and 368,152 shares valued at $280,475 to 6 employees for performance awards.
-
VetStem licensing agreement terminated
The VetStem licensing agreement was terminated on July 24, 2026, following continued negotiations, representing a change in the company’s licensing arrangements.
What to watch
-
Private-placement dilution
The company issued 937,500 shares for $750,000 in a private placement, increasing the share count and creating dilution risk for existing holders.
-
Additional equity compensation dilution
The company issued 368,152 shares valued at $280,475 to 6 employees and 200,000 shares valued at $160,000 to a service provider during the quarter, indicating additional equity-based compensation and service costs.
-
OSHA and licensing uncertainty
The filing states that risks related to an OSHA complaint could materially affect the business, financial condition, and future results; the filing also states that the VetStem licensing agreement terminated on July 24, 2026.
Management's outlook
The provided 10-Q text does not disclose quantitative revenue or EPS guidance, and no outlook, liquidity outlook, or capital-spending forecast is included.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.